Is slow coronary flow related with inflammation and procoagulant state;Koroner yavaş akim inflamasyonla ve prokoagülan durumla ilişkili midir?

Anadolu Kardiyoloji Dergisi

Volumn 5, Issue 1, 2005, Pages 3-7

  Yazici, Mustafa ^b   Aksakal, Emre ^a   Demircan, Sabri ^b   Şahin, Mahmut ^b   Saǧkan, Olcay ^b  

^a Samsun Devlet Hastanesi   (Turkey)

^b ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

C reactive protein; Coronary slow flow; Inflammation; Procoagulant activity

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

ADULT; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD CLOTTING; BLOOD SAMPLING; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; FEMALE; HEALTH CARE FACILITY; HOSPITAL ADMISSION; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PATHOGENESIS; VENOUS BLOOD;

C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CORONARY ANGIOGRAPHY; FEMALE; FIBRINOGEN; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; SEVERITY OF ILLNESS INDEX; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

EID: 14944343858     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Van Lierde J, Vrolix M, Sionis D, De Geest H, Piessens J. Lack of evidence for small vessel disease in a patient with "slow dye progression" in the coronary arteries. Cathet Cardiovasc Diagn 1991; 23: 117-20.
2. Cesar LA, Ramires JA, Serrano Junior CV, et al. Slow coronary run-off in patients with angina pectoris: clinical significance and thallium-201 scintigraphic study. Braz J Med Biol Res 1996; 29: 605-13.
3. Tambe AA, Demany MA, Zimmerman HA, Masearanhas E. Angina pectoris and slow flow velocity of dye in coronary arteries, a new angiographic finding.Am Heart J 1972; 84: 66-71.
4. Gibson CM, Cannon CP, Daley WL, et al. TIMI frame count. A quantitative method of assessing coronary artery flow. Circulation 1996; 93: 879-88.
5. Goel PK, Gupta SK, Aggarwal A, Kapoor A. Slow coronary flow: a distinct angiographic subgroup in Syndrome X. Angiology 2001; 52: 507-14.
6. Wilson RF, White CW. Intracoronary papaverine: an ideal coronary vasodilator for studies of the coronary circulation in conscious humans. Circulation 1986; 73: 444-51.
7. Vrints C, Herman AG. Role of the endothelium in the regulation of coronary artery tone. Acta Cardiol 1991; 46: 399-418.
8. Cannon RO 3rd, Epstein SE. "Microvascular angina" as a cause of chest pain with angiographically normal coronary arteries. Am J Cardiol 1988; 61: 1338-43.
9. Mosseri M, Yarom R, Gotsman MS, Hasin Y. Histologic evidence for small vessel coronary artery disease in patients with angina pectoris and patent large coronary arteries. Circulation 1986; 74: 964-72.
10. Cermak J, Key NS, Bach RR, Balla J, Jacop HS, Vercelotti GM. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 1993; 82: 513-20.
11. Beltrame JF, Limaye SB, Horowitz JD. The coronary slow flow phenomenon - a new coronary microvascular disorder. Cardiology 2002; 97: 197-202.
12. Yazici M, Demircan S, Aksakal E, et al. Yavaş koroner akimli hastalarda plazma insülin, glukoz, lipid düzeyleri ve düzeltilmiş TIMI kare sayisi ile ilişkisi. Anadolu Kardiyol Derg 2003; 3: 222-6.
13. Chambers J, Bass C. Chest pain with normal coronary anatomy: a review of natural history and possible etiologic factors. Prog Cardiovasc Dis 1990: 33: 161-84.
14. Kaski JC, Rosano GM, Collins P, Nihoyannopoulos P, Maseri A, Poole-Wilson PA. Cardiac syndrome X: clinical characteristics and left ventricular function. Long-term follow-up study. J Am Coll Cardiol 1995: 25: 807-14.
15. Diver DJ, Bier JD, Ferreira PE, et al. Clinical and arteriographic characterization of patients with unstable angina without critical coronary arterial narrowing (from the TIMI-IIIA Trial). Am J Cardiol 1994; 74: 531-7.
16. Nava Lopez G, Monteverde C, Jauregui R, et al. X syndrome: angiographic findings. Arch Inst Cardiol Mex 1989; 59: 257-65.
17. Chauhan A, Mullins PA, Taylor G, Petch MC, Schofield PM. Both endothelium-dependent and endothelium independent function is impaired in patients with angina pectoris and normal coronary angiograms. Eur Heart J 1997; 18: 60-4.
18. Koren W, Koldanov R, Peleg E, Rabinowitz B, Rosenthal T. Enhanced red cell sodium-hydrogen exchange in microvascular angina. Eur Heart J 1997; 18: 1296-9.
19. Yazici M, Balci B, Demircan S, et al. Yavaş koroner akimli hastalarda plazma ET-1 düzeyleri ve düzeltilmiş TIMI kare sayisi ile ilişkisi. Türk Kardiyol Dern Arş 2002; 30: 466-72.
20. Adamopoulos S, Rosano GM, Ponikowski P, et al. Impaired baroreflex sensitivity and sympathovagal balance in syndrome X. Am J Cardiol 1998; 82: 862-8.
21. Yeşildag O, Yazici M, Yilmaz Ö, Uçar R, Saǧkan O. The effect of aminophylline infusion on the exercise capacity in patients with syndrome X. Acta Cardiol 1999; 54: 335-7.
22. Peng SK, French WJ. Morphological changes in small vessels on endomyocardial biopsy. Ann Clin Lab Sci 1986; 16: 180-8.
23. Suzuki H, Takeyama Y, Koba S, Suwa Y, Katagiri T. Small vessel pathology and coronary hemodynamics in patients with microvascular angina. Int J Cardiol 1994; 43: 139-50.
24. Mangieri E, Macchiarelli G, Ciavolella M, et al. Slow coronary flow: Clinical and histopathological features in patients with otherwise normal epicardial coronary arteries. Cathet Cardiovasc Diagn 1996; 37: 375-81.
25. Opherk D, Zebe H, Weihe E, et al. Reduced coronary dilatory capacity and ultrastructural changes of the myocardium in patients with angina pectoris but normal coronary arteriograms. Circulation 1981; 63: 817-25.
26. Pakdemir H, Çamsari A, Parmaksiz T. Yavaş koroner akim diffüz ateroskelrozun bir bulgusu olabilir: FFR ve IVUS çalişmasi. Türk Kardiyol Dern Arş 2003; 31: 270-8.
27. Baumgart D, Haude M, Gorge G, et al. Augmented alpha-adrenergic constriction of atherosclerotic human coronary arteries. Circulation 1999; 99: 2090-7.
28. Berk BC, Weintroub WS, Alexander RW. Elevation of C-reactive protein in active coronary artery disease . Am J Cardiol 1990; 65: 168-72.
29. Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC. C-reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. 1996; 312: 1061-5.
30. Vallance P, Collier J, Bhagat K. Infection, inflammation and infarction: does acute enclothelial dysfunction provide a link. Lancet 1997; 349: 1391-5.
31. Kinlay S, Selwyn AP, Libby P, Ganz P. Inflammation, the endothelium and the acute coronary syndromes. J Cardiovasc Pharmacol 1998; 32(Suppl): S62-6.
32. Libby P. Molecular bases of the acute coronary syndromes. Circulation 1995; 91: 2844-50.
33. Munro JM, Cotran RS. The pathogenesis of atherosclerosis: atherogenesis and inflammation. Lab Invest 1988; 58: 249-61.
34. Ruggeri ZM. Structure and function of von Willebrand factor. Thromb Haemost 1999; 82: 576-84.